VNRX insider trading

NYSE American Healthcare

VOLITIONRX LTD — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
562
Last 90 days
18
Buys / sells
16% / 3%
Market cap
$25.28M

About VOLITIONRX LTD

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.

Company website: volition.com

VNRX insider activity at a glance

FilingIQ has scored 562 insider transactions for VNRX since Dec 13, 2012. The most recent filing in our index is dated Mar 17, 2026.

Across the full history, 89 open-market purchases and 15 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VNRX insider trades is 50.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for VNRX?
FilingIQ tracks 562 Form 4 insider transactions for VNRX (VOLITIONRX LTD), covering filings from Dec 13, 2012 onwards. 18 of those were filed in the last 90 days.
Are VNRX insiders net buyers or net sellers?
Across the full Form 4 history for VNRX, 89 transactions (16%) were open-market purchases and 15 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VNRX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VNRX in?
VOLITIONRX LTD (VNRX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $25.28M.

Methodology & sources

Every VNRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.